Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move
(NASDAQ: $NEPT) (CSE: $CHOO.C) (NYSE: $CGC) (CSE: $TTT.C) (TSXV: $NRTH.V)
Delta, Kelowna, BC –June
17, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/06171NEPT-CHOO-CGC-TTT-NRTH.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
Today we are looking at a few early
announcements.
Neptune Wellness
Solutions Inc. (NASDAQ:NEPT) (TSX:NEPT) announced that its wholly owned subsidiary,
9354-7537 Québec Inc. has received a notification letter from Health Canada
indicating that all requested license amendments have been approved.
The
scope of the amendment received from Health Canada permits expansion of
cannabis operation areas to include an additional extraction room where Neptune
will perform cold ethanol extraction. Ethanol extraction is faster and more
cost effective than the CO2 extraction currently used and will
increase Neptune's input capacity from 30,000 kg to 200,000 kg.
\
This
seven-fold increase in the Company's capacity will accelerate production and
enable fulfilment of commercial commitments. Start-up activities will begin
immediately, including the final stages of commissioning the equipment, and
Neptune will ramp up commercial operations on a progressive basis during the
second fiscal quarter.
The
amendment from Health Canada also includes expansion for an encapsulation room
where Neptune will produce cannabis oil capsules using the Licaps® technology
licensed from Lonza Group AG. The encapsulation equipment is commissioned and
ready for commercial operations with a capacity of up to 200 million capsules
annually. The Licaps® technology supports differentiated product offerings
through its various delivery systems, colours and branding possibilities.
Furthermore, this is an effective technology for variable and multiple product
formulation runs.
"Congratulations
are in order as this announcement marks another milestone achieved by our team
by successfully meeting the stringent Health Canada requirements," said
Jim Hamilton, CEO of Neptune. "The new regulations regarding cannabis
edibles, extracts and topicals recently published by Health Canada are expected
to result in significant additional demand for cannabis extraction and
purification services. With our increased extraction capacity, Neptune is now
well positioned to benefit from this rapidly growing market. In addition, our
cannabis oil capsule technology provides the company a differentiated offering
for which there is strong demand."
Choom™ (CSE: CHOO) (OTCQB: CHOOF), announced that Choom Niagara, the first legal, adult
use cannabis store to operate in Niagara Falls, ON has produced over $49,000 in
sales on its opening day.
"We are really happy with the turnout
we had for Choom Niagara's opening day." states Chris Bogart, President
and CEO of Choom "We've had a lot of support from the local community, and
we're excited to bring Choom to Niagara Falls. The feedback from our customers
has been fantastic, and that is a testament to our dedicated staff and in-store
experience. Doing over $49,000 in sales
on the first day of operation is a great milestone for us and our team who have
worked so hard to get where we are today."
Canopy Growth
Corporation (TSX:WEED)(NYSE:CGC) highlighted recent developments that are fueling its international
progress in emerging medical cannabis and CBD markets. The Company's global
three-prong strategy includes a focus on building best-in-class global GMP
(Good Manufacturing Practices) infrastructure, advancing clinical research
programs and best-in-class education and sales programs through its Spectrum
Therapeutics medical division, and launching CBD products where regulatory
environments allow. Recent highlights include:
Latin America:
Furthering
access to these new markets, Canopy Growth has entered into a multi-year
agreement with Procaps S.A.S ("Procaps"), a global company based in
Colombia. Procaps develops, manufactures, and markets over-the-counter medications
and nutritional supplements for a number of international pharmaceutical
companies. Procaps exports to more than 50 international markets, including
highly regulated jurisdictions such as the United States, where they are GMP
certified by the US Food and Drug Administration ("US-FDA"). Through
the agreement, Canopy Growth will leverage Procaps' industry-leading
formulation and encapsulation capacity, which is especially critical in serving
Latin American markets where there is a strong regulatory preference for
oil-based products, including softgels. The agreement covers a number of
different product formats.
In
Colombia, Canopy Growth is licensed
to produce over 13.6 million sq. ft. of THC or CBD dominant cannabis, making
its Neiva license one of the largest in the world and positioning the Company
to meet the emerging regional demand for medical cannabis and CBD products.
While only a portion of the cultivation area is in use, the Company will scale
operations as market demand dictates. The Company has also completed
compassionate sales of Canadian-produced Spectrum Therapeutics products to both
Chilean and Brazilian patients, validating the potential of serving patients
through an import model while its Latin America operations scale and regional
regulations advance to support greater market access.
Asia-Pacific:
In
Australia, Spectrum Therapeutics
received its first shipment of medical cannabis oil in April 2019 and shortly
thereafter began sales to medical cannabis patients in May 2019. The medical
market is expanding in Australia as regulations mature and patients have
greater access to medical cannabis. Country-wide patient registrations have
increased tenfold over the last year to more than 1,300 today. Spectrum
Therapeutics intends to support Australian patients through imports until its
domestic facilities are fully operational. Construction of its Victoria-based
greenhouse and post-production facility is currently underway.
Europe:
In
Denmark, Spectrum Therapeutics
received the necessary licensing from the Danish Medicines Agency for its
Odense facility, allowing the Company to grow, harvest, export and sell medical
cannabis in dried flower form. To its knowledge, Spectrum Therapeutics is the first
Canadian company to receive a federal production licence in Denmark. The
facility, certified in both Good Agricultural and Collection Practices (GACP)
as well as GMP designations, is the backbone of the Company's regional supply
chain and will support the growing demand for Spectrum Therapeutics products
across Europe. Additionally, following its acquisition of a licence to grow and
produce cannabis in Spain, the
Company is actively developing plans for its second site in Europe.
The
Company also continues to integrate the recent strategic acquisitions of
German-based Storz & Bickel, a global leader in medical device and
vaporizer technology, German-based C3 Cannabinoid Compound Company, a leading
European producer of Dronabinol, and UK-based ThisWorks. Integration of these
global leaders into the Canopy product offering and global sales structure will
increase revenues, accelerate intellectual property development, and further
advance and expand clinical research.
Africa:
In
Lesotho, Spectrum Therapeutics has been granted a medical production licence
covering two facilities in the country, including 21 million sq. ft. of outdoor
grow space and 322,000 sq. ft. of indoor, outdoor and greenhouse space
combined, respectively, where CBD dominant and CBD-THC balanced varieties can
be cultivated. With these licensed areas, Spectrum Therapeutics to its
knowledge now owns one of the largest legal outdoor CBD cultivation sites on
the continent of Africa, some of which is currently operational.
Spectrum
Therapeutics has also acquired 12 hectares of land located in the Atlantis
Economic Zone in the city of Cape Town in order to establish licensed
production operations in South Africa.
The Company has submitted the necessary applications for a cultivation and
post-harvest processing facility licence, which will complement its current
production capabilities in Lesotho.
For
years, Canopy Growth has taken the long-view, leveraging its substantial cash
position to lay the foundation for a global, revenue-generating network. These
latest milestones, from world-wide land acquisitions and partnerships, facility
developments, licence accreditations, crop cultivation - and sales - validate
the Company's efforts and strategic investments, strengthening its position as
the global leader, poised to capitalize on emerging markets.
Today
at the second annual World Cannabis Congress, Shoppers Drug Mart announced a new initiative with software company, TruTrace Technologies (CSE: TTT)(OTC: BKKSF) to develop and deploy a
blockchain-secured pilot program intended to increase transparency,
interoperability and product identification within the medical cannabis
industry.
The
Pilot Program will use TruTrace's StrainSecure™ technology as a central hub for
identity management, asset tracking, validation, and product authentication.
StrainSecure will also serve as a master registry for standardized testing,
product verification, and quality assurance.
"We've
gone to great lengths over the past six years to fully understand the
challenges and opportunities that exist within the medical cannabis industry
and taken steps to apply similar principles from traditional medicine to this
new industry. The source of medical cannabis must be traceable and accountable
for patients and practitioners to feel confident about it as a treatment,"
said Ken Weisbrod, Vice President, Shoppers Drug Mart. "When a patient
takes medication, there is an expectation that it is standardized, and they can
expect consistent clinical outcomes and results. Although that's not always a
guarantee within the medical cannabis industry at the moment, we're hoping this
new program can help change that."
"This
is a significant milestone that brings our technology together with one of the
most trusted brands in Canada," said TruTrace Technologies CEO Robert
Galarza. "We believe it is a testament to our technology's ability to
bring transparency and integrity to the cannabis industry and our shared
mission. This initiative should help researchers and clinicians to match
therapeutic outcomes to specific genetic and chemical profiles, and provide
physicians, pharmacists, and patients with greater confidence in the products
they prescribe or consume."
Phase
1 of the pilot program is expected to be completed by July 31, with full
production and implementation targeted for late November 2019.
48North Cannabis
Corp.(TSXV:NRTH) is inviting Canadians to
"See the
Good" as it
launches a first-of-its kind video series dedicated to the cultivation of
outdoor, sun-grown cannabis.
48North's
Good Farm, which is located in Brant County and received one of the first
outdoor cannabis licences in Canada, is poised to produce 40,000 kilograms of
dried cannabis this year from 100 acres (3.7 million square feet of cultivation
space) of organic farm space, making it one of the largest licensed cannabis
operations in the world.
Good
Farm has a number of strategic advantages, including: ultra-low-cost cannabis,
environment-friendly and energy-efficient production, in addition the farm
provides a source of relief to the national shortage of recreational cannabis.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
